🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

JEENA SIKHO LIFECARE LTD JSLL NSEPHARMA

Healthcare · Medical Care Facilities · India
https://jeenasikho.com

Jeena Sikho Lifecare Limited trades in ayurvedic medicines in India. The company offers ayurvedic products under the Shuddhi brand name. It also provides services, including in-patient, out-patient, 72 hours health camps, Panchakarma therapies, dietary support and nutrition guidance, home-based healthcare services, and healthcare support centre services. In addition, the company operates clinics under the Shuddhi Ayurveda, Shuddhi Clinics, Hospital & Institution of Integrated Medical Sciences, Shuddhi Wellness Clinics & Hospital, Shuddhi Ayurveda Panchakarma Hospital, and Shuddhi Panchakarma Day Care Clinic names. Jeena Sikho Lifecare Limited was founded in 2009 and is headquartered in Zirakpur, India.

READ MORE ›
₹614.95
-71.45% 1Y

Market & Price

Market Cap
₹7,643.87 Cr
Current Price
₹614.95
High / Low (52W)
₹2,153.69 / ₹414.59
Beta
1.19

Valuation

Stock P/E
35.96
Industry PE
37.60
Forward P/E
13.82
PEG Ratio
-
Book Value
₹28.47
Price to Book
21.60
P/S
10.54
EV/EBITDA
26.32
Dividend Yield
0.18%

Profitability & Returns

ROCE
44.40%
ROE
-
ROA
-
Profit Margin
29.35%
Op Margin
40.36%
EPS (Latest Qtr)
₹5.35
EPS (TTM)
₹17.10

Balance Sheet & Liquidity

Debt/Equity
0.30
Quick Ratio
-
Current Ratio
-
Debt
₹106.22 Cr
Total Assets
₹328.31 Cr
Current Assets
₹152.16 Cr
Working Capital
₹99.89 Cr

Ownership

Promoter Holding
74.72%
Chg in Prom Hold
-
FII / Inst Holding
0.17%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
₹7,638.38 Cr
Total Revenue (TTM)
₹725.06 Cr
EBITDA
₹290.15 Cr
Free Cash Flow
-
Operating Cash Flow
-
Shares Outstanding
₹12.43 Cr
Gross Margin
91.01%
Payout Ratio
6.44%

Growth (CAGR)

Revenue 5Y
47.37%
Profit 5Y
100.64%
Revenue (YoY)
91.60%
Earnings (YoY)
404.70%

PROS

  • Healthy ROCE of 44.4%.
  • Excellent profit margin of 29.4%.
  • Compounding revenue at 47.4% over 5 years.
  • Profit CAGR of 100.6% over 5 years.

CONS

  • Trading 71.5% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

NSE TradingView Screener.in

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 JSLL JEENA SIKHO LIFECARE LTD NSEPHARMA 614.95 35.96 ₹7,643.87 Cr 0.18% 44.40% - 47.37% 100.64%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,799.20 37.59 ₹4.32 L Cr 0.92% 17.94% 14.72% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 6,667.00 68.97 ₹1.77 L Cr 0.45% 18.96% 16.19% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,410.80 68.96 ₹1.49 L Cr 0.86% 9.06% 16.98% 13.27% 20.21%
5 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,401.00 29.16 ₹1.13 L Cr 0.93% 14.88% 11.74% 7.23% 11.45%
6 DRREDDY Dr. Reddy's Laboratories Limited NIFTY50NSEAIPHARMA 1,303.50 25.90 ₹1.09 L Cr 0.61% 14.00% 11.83% 10.96% -2.35%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,077.70 21.51 ₹1.08 L Cr 0.09% 19.24% 18.32% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,267.70 19.49 ₹1.04 L Cr 0.53% 28.42% 26.91% 19.10% 131.46%
9 MANKIND Mankind Pharma Limited NIFTY_MIDNSEPHARMA 2,375.60 51.29 ₹98,090.71 Cr 0.08% 13.78% 12.45% 17.73% 14.28%
⚙Ad space

Quarterly Results

Figures in INR.

Metric Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue -115.69 Cr139.25 Cr174.29 Cr189.85 Cr221.68 Cr
Cost of Revenue -15.78 Cr16.71 Cr11.09 Cr24.09 Cr24.20 Cr
Gross Profit -99.91 Cr122.54 Cr163.19 Cr165.76 Cr197.48 Cr
Operating Expenses -78.77 Cr79.52 Cr94.09 Cr84.13 Cr108.02 Cr
Operating Income -21.14 Cr43.02 Cr69.10 Cr81.63 Cr89.46 Cr
EBITDA -29.99 Cr41.34 Cr79.82 Cr93.47 Cr103.29 Cr
Interest Expense -3.78 Cr-7.07 Cr1.66 Cr4.35 Cr3.10 Cr
Pretax Income -17.74 Cr48.40 Cr68.51 Cr78.73 Cr88.93 Cr
Tax Provision -4.10 Cr12.28 Cr17.24 Cr19.98 Cr22.33 Cr
Net Income -13.64 Cr36.13 Cr51.27 Cr58.75 Cr66.66 Cr
Diluted EPS 2.141.06-4.124.725.35

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025
Revenue 146.55 Cr203.90 Cr324.41 Cr469.07 Cr
Cost of Revenue 16.47 Cr21.77 Cr31.24 Cr54.22 Cr
Gross Profit 130.08 Cr182.13 Cr293.17 Cr414.85 Cr
Operating Expenses 115.29 Cr135.89 Cr205.26 Cr297.08 Cr
Operating Income 14.79 Cr46.24 Cr87.91 Cr117.77 Cr
EBITDA 19.51 Cr48.20 Cr99.09 Cr131.27 Cr
Interest Expense 1.11 Cr54.69 L7.10 L49.31 L
Pretax Income 15.09 Cr44.53 Cr93.92 Cr122.07 Cr
Tax Provision 3.90 Cr10.79 Cr24.71 Cr31.34 Cr
Net Income 11.23 Cr33.74 Cr69.21 Cr90.73 Cr
Diluted EPS 0.902.745.577.29

Compounded Sales Growth

5 Years:47.37%
1 Year:91.60%

Compounded Profit Growth

5 Years:100.64%
1 Year:404.70%

Stock Price Performance

1 Year:-71.45%
6 Months:-10.02%
3 Months:-8.39%
1 Month:-8.96%

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets 61.54 Cr151.03 Cr220.53 Cr328.31 Cr
Current Assets 21.53 Cr77.48 Cr144.34 Cr152.16 Cr
Cash & Equivalents 2.19 Cr31.62 Cr59.86 Cr24.45 Cr
Inventory 6.36 Cr4.10 Cr7.19 Cr11.55 Cr
Receivables 9.04 Cr22.07 Cr41.19 Cr97.63 Cr
Total Liabilities 25.06 Cr25.23 Cr28.28 Cr55.29 Cr
Current Liabilities 23.89 Cr24.60 Cr27.41 Cr52.27 Cr
Long Term Debt 80.80 L53.95 L32.16 L42.92 L
Total Debt 7.43 Cr80.80 L53.95 L10.73 Cr
Total Equity 36.52 Cr125.80 Cr192.25 Cr273.02 Cr
Shares Outstanding 12.43 Cr12.43 Cr12.43 Cr12.43 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow 16.35 Cr17.17 Cr36.69 Cr68.63 Cr
Investing Cash Flow -18.49 Cr-57.23 Cr-18.05 Cr-70.37 Cr
Financing Cash Flow -4.51 Cr48.00 Cr-3.44 Cr-69.14 L
Capital Expenditure -17.08 Cr-38.20 Cr-15.54 Cr-41.83 Cr
Free Cash Flow -72.51 L-21.03 Cr21.15 Cr26.80 Cr
Net Change in Cash -6.65 Cr7.94 Cr15.20 Cr-2.43 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025
Gross Margin % 88.8%89.3%90.4%88.4%
Operating Margin % 10.1%22.7%27.1%25.1%
Net Margin % 7.7%16.5%21.3%19.3%
ROE % 30.8%26.8%36.0%33.2%
ROCE % 39.3%36.6%45.5%42.7%

Shareholding Pattern

Insiders
74.72%
Institutions
0.17%
Public Float
0.69%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for JSLL

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space